NeoStem Inc (NBS): Neostem Stands To Benefit From Stem-Cell Deals – Seeking Alpha
|
NeoStem Inc (NBS): Neostem Stands To Benefit From Stem–Cell Deals
Seeking Alpha The age of stem cell acceptance has arrived. Last week shares of OncoMed Pharmaceuticals, Inc. (OMED) soared over 100%, moving from a $14.00 close on December 2nd to an intraday high of $32.39 on December 4th. The news that drove shares this high … |
